TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in peripapillary retinal nerve fiber layer (RNFL) thickness (µm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in macular ganglion cell-inner plexiform layer thickness (µm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in optic nerve (ON) head cup-to-disc ratio (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Progression-Free Survival (PFS) Duration
Endpoint domain: Mortality/survival
Primary endpoint: Whole body substrate kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of EVs from muscle, liver, and brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of EVs from muscle, liver, and brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper trapezius' Surface Electromyographic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticipatory Reward Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Effort-Based Decision Making
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Monetary Reward Sensitivity during Effort-Based Decision Making
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reward Sensitivity for Non-Monetary Reward
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sustained Attention to Response Task (SART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Piper Fatigue Scale (PFS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Early socio-communicative skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Early socio-cognitive skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Socio-emotional development
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Menstruation Symptom Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the McGill pain questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molecular and radiological landscape of PDAC tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Biological properties of Adipose Tissue dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tumor growth, metastasis, and therapeutic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in surgical fear levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in patients' perceptions of nursing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MiniBEST test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Healthy Lifestyle behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in score on the Liebowitz Social Anxiety Scale, Self-Report (LSAS-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Statin prescription within 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in financial distress
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Muscle state evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in kilocalorie consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Correlation of PET-CT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of S-Detect diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lncRNA Biomarker expression before breakfast intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lncRNA Biomarker expression after breakfast intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of stroke severity classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12 month Expanded Prostate Cancer Index Composite (EPIC) genitourinary score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 12 month Expanded Prostate Cancer Index Composite (EPIC) gastrointestinal score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Western-Ontario Shoulder instability Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PROMIS Physical function (PF) CAT
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants with Recurrent Instability
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of In-stent restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in antioxidants enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in brain neuroplasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in bone metabolism I (Formation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in bone metabolism II (Resorption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Agreement between P-tau217 concentration measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extracellular volume (ECV, %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core temperature (Peak) during daytime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate variability: SDNN during daytime
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive function during daytime
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of life - application of Kansas City Cardiomyopathy Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life - Difference in the 6-minute walk test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of subjects with chest pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with shortness of breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hemoglobin assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Suturing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rates of technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time from SE diagnosis to first dose of BZD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentration of posaconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best Positive end-expiratory pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chronic Pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer (GMT) of hemagglutination inhibition (HI) antibodies against H5N8 strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean fold increase (GMFI) of HI antibodies against H5N8 strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentages of subjects with seroconversion by HI against H5N8 strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with HIV-1 RNA <50 copies/mL at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants experiencing ≥1 adverse event (AE) through Week 48
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants discontinuing from study treatment due to an AE through Week 48
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of AYAHIV with viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive Aspect of Caregiving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neuropsychiatric Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of thromboembolic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of individuals achieving cardiovascular prevention goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difficult biliary cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of subjects assessed at 12 weeks post-IRE
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of subjects assessed at 6 weeks post-MRgRT within 1 year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cortactin expression in urothelial carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: N-Back Computerized Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Trail Making Test - Parts A & B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction of tumor cells in the cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in non-specific low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of the outcome of conversion therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite outcome of mortality or functional deterioration on day 30
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with CRS in particular degree of severity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Vascular Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in percentage of CGM glucose readings > 120 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Deviation of linear measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in PSA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: general disaster preparedness belief level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: level of disaster literacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Histopathological confirmation of complete tumor regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Acoustic changes in the speech signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment related adverse events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Benefit Rate (CBR) of Tumour Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Impact score of Strength and Difficulties (SDQ) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Degree of dependency and disability in everyday life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Short term recovery of Cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Characteristics of people admitted for acute community-acquired pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance Quality Rating Scale (PQRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: complications of laryngeal mask insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of sUA levels below 420 μmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Non-motor symptoms scale (NMSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Bladder over activity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Internal temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole body sweat rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of one additional comorbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digital signature of sedentary lifestyle and PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sufentanil-induced cough
Endpoint domain: Adverse events/effects
Primary endpoint: Motivation level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physician rating of electroanatomic map
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nocturnal oxyhemoglobin saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurocognitive functioning (working memory and verbal comprehension)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: irrigant penetration depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Time to complete each transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical load for movement of the hoist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective data on comfort, ease of use, effort, and willingness to adopt
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total nasal symptom Score (TNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Health PHQ9
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Health GAD7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Health PCL5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with bladder irrigation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients given enema
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of times indwelling catheter was changed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients with co-diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Limited G3L Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical remission rate at 14 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission rate at 54 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body composition change (fat mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Body Composition (fat-free mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Executive Function (inhibition)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Executive Function (cognitive flexibility)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in executive function (working memory)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Nasal patency measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analog scale score (VAS) ≤3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of Muscle Strength in Both Hands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Pain Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth mobility: force control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth Mobility: labial-lingual/palatal displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma glucose (absolute values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum insulin (absolute values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum C-peptide (absolute values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants with DS-TB reporting severe Adverse events (AEs) (≥ Grade 3) and/or Serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with pulmonary DS-TB with unfavorable outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Concentration (Cmax) of LY3471851
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of LY3471851
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percent weight change at intervention completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent weight change three months post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transition time from tube to full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to accomplish exclusive oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfer independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline-Adjusted 24-Hour NIHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Task-related oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Cognitive Impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: CEA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort level during the procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in general symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of dietary fiber in grams
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of human milk oligosaccharides, plant-based nutrients and fatty acids in breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Microbiota profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual dysfunction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: semen parameters improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: symptoms improvement (pain and swelling)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effects of intravesical chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: GMT of subject's anti- SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of 4-fold rise of anti- SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Wound Healing Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prostate specific antigen (PSA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall quality of life parameters
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Activities Scale for Kids (ASKp)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diameter of tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Baseline Post-Concussion Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitigation of food insecurity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clock genes expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes